News

Academic Leaders Join Advisory Board of Assay Depot, the World's First Drug Discovery Outsourcing Marketplace

SAN DIEGO-(Business Wire)-September 3, 2008 - Assay Depot announced today that leading researchers from Harvard, Stanford, the University of California, San Francisco (UCSF) and the University of Texas had joined its Advisory Board. Assay Depot is the world’s first full-service outsourcing marketplace for pharmaceutical research services.

“Many academic researchers are interested in translating their basic research discoveries into new clinical treatments for disease,” commented Randy King, PhD, Professor, Harvard Medical School. “This innovative marketplace enables academic scientists to access drug discovery services that until recently were only available within industry laboratories.”

Assay Depot’s outsourcing marketplace provides an easy-to-use, information-rich shopping experience for research scientists. At assaydepot.com, a researcher can compare detailed research service descriptions, view customer reviews, place online orders, request quotes, and retrieve their data report from a single secure location.

“Assay Depot is committed to ensuring that academic scientists have access to a comprehensive selection of peer-reviewed research services,” commented Charles Dowding, PhD, Vice President of Research, Assay Depot. “Working with world-class scientists who understand the challenges facing academic researchers really makes a difference.”

Advisory Board Members:

Randall W. King MD, PhD is an Associate Professor in the Department of Cell Biology at Harvard Medical School. Prior to joining the faculty at Harvard Medical School, Dr. King was a fellow at the Institute of Chemistry and Cell Biology at Harvard. He co-founded the drug discovery companies Kalypsys, Inc. in 2001 and Makoto Life Sciences, Inc. in 2006.

Julie A. Theriot, PhD is an Associate Professor at the Stanford University School of Medicine, with appointments in the Department of Biochemistry and the Department of Microbiology & Immunology. She was named as an Investigator of the Howard Hughes Medical Institute in 2008. Prior to joining the faculty at Stanford, Dr. Theriot was a Whitehead Fellow at the Whitehead Institute for Biomedical Research. She has won numerous awards for both research and teaching, including a MacArthur Foundation Fellowship in 2004.

Bruce R. Conklin, MD is a Senior Investigator at the Gladstone Institute of Cardiovascular Disease and a Professor at the University of California, San Francisco, with appointments in the Departments of Medicine and Cellular & Molecular Pharmacology and the Division of Medical Genetics. He consults for several leading biotechnology companies, and he is the founder of the widely used public resources, BayGenomics, GenMAPP and WikiPathways.

P. Renee Yew, PhD is an Associate Professor in the Department of Molecular Medicine at the University of Texas Health Science Center at San Antonio in the Institute of Biotechnology, where she studies cell cycle dynamics. Prior to joining the faculty at the University of Texas, she was a Postdoctoral Fellow in the Department of Cell Biology at Harvard Medical School.

Nathanael Gray, PhD is an Assistant Professor in the Department of Cancer Biology at the Dana Farber Cancer Research Institute with a joint appointment in the Department of Biological Chemistry and Molecular Pharmacology at Harvard Medical School. Prior to joining the faculty at Harvard Medical School, he was the Director of Biological Chemistry at the Genomics Institute of the Novartis Research Foundation (GNF).

Full biographies are located at http://www.assaydepot.com/site/advisory_board

About Assay Depot

Assaydepot.com is an online marketplace for research services that will be launched September 15, 2008. By acting as a single point of contact between researchers and service providers, the marketplace dramatically improves the efficiency of outsourcing. At Assay Depot, we make outsourcing easy^TM.

Send this news item to a friend.

Print This Page